← Eichor
Condition: Generalised Lipodystrophy Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Generalised Lipodystrophy

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

PET Imaging Targeting Granzyme B Predicts Immunotherapy Efficacy in Diffuse Large B-cell Lymphoma
Phase N/A · 1 location(s) · Ruijin Hospital · NCT0675577564Cu-GRIP B in Patients With Advanced Malignancies
Phase 1/Phase 2 · 1 location(s) · Rahul Aggarwal · NCT05888532MEASuRE: Metreleptin Effectiveness And Safety Registry
Phase N/A · 28 location(s) · Chiesi Farmaceutici S.p.A. · NCT02325674Efficacy and Safety of Mibavademab in Adult and Pediatric Patients With Generalized Lipodystrophy
Phase 3 · 3 location(s) · Regeneron Pharmaceuticals · NCT07220785Pulmonary Hypertension Biorepository and Registry
Phase N/A · 1 location(s) · University of Kansas Medical Center · NCT04808596GzmB-PET/CT to Evaluate Neoadjuvant Therapy Efficacy in Breast Cancer
Phase N/A · 1 location(s) · Shanghai Jiao Tong University School of Medicine · NCT06725940
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.